ADVERTISEMENT
News
Diabetes Drug Recalled
10/25/2019
The recall affects 30-count bottles of pioglitazone hydrochloride tablets, 15 mg (NDC 33342-054-07), from lot BPF901A (Exp. 12/21). The product was sent to eight distributors that may have further distributed the medication.
Macleods Pharma initiated the recall September 23, 2019. On October 11, 2019, the FDA designated the recall Class II, communicating use of the affected drug may cause temporary or medically reversible adverse health consequences or a remote possibility of serious harm.
Pioglitazone is a prescription medication used to treat patients with type 2 diabetes.
—Jolynn Tumolo